AI and Rare Disease Treatment: A Revolution in Progress Find out how artificial intelligence is revolutionizing the treatment of rare diseases, tackling the shortage of skilled labor in the biotech sector.
Gene editing and beta-thalassaemia: first clinical results A new gene-editing approach shows clinical results in beta-thalassaemia, with greater precision, fewer errors and reduced dependence on transfusions.